A Public Service Announcement
As of the 1st September 2023 all secondary school students in the UK will be offered Fluenz, a nasal spray vaccine for influenza. This vaccine comes with significant adverse event risks as reported on the WHO’s own database – www.vigiaccess.org – where 311,980 adverse events are recorded so far including Facial Paralysis, Heart Inflammation, Pericarditis, Brain Damage, Meningitis, Encephalitis, and Guillain-Barre. To see the full list of side effects, go to www.vigiaccess.org, click “Search Database”, and enter “FLUENZ”. Curiously, the adverse effects profile for FLUENZ, is similar to COVID vaccines with a peak for neurological effects. This suggests that this “nasal vaccine” may be effecting more than the respiratory system, but also acting systemically – effecting other organs such as the brain. A closer look at the neurological effects reveals an alarming incidence of tremor and paralysis – indicating possible auto-immune attack upon nerve cells. Within 4 weeks of rollout of Fluenz in primary schools, 19 children are reported to have died. Fluenz is manufactured by Astrazeneca.The AZ covid injection was banned by EU countries from March 2021 onwards, due to the risk of blood clots.